The present disclosure relates to sensing devices, systems, and their methods of use for aiding transcutaneous magnetic stimulation (tMS) therapy, such as for the treatment, alleviation, and the management of pain. The sensing device being configured for determining and measuring the efficacy thereof. Particularly, the present disclosure is directed to providing sensing devices, systems including the same, and their methods of use in identifying and targeting one or more sources of pain, such as chronic neuropathic pain, as well as for facilitating in the treatment thereof.

An actuated magnetic field is generated at a plurality of distinct frequencies that at least partially cancels an outside magnetic field at the plurality of distinct frequencies, thereby yielding a total residual magnetic field. The total residual magnetic field is coarsely detected and a plurality of coarse error signals are respectively output. The total residual magnetic field is finely detected and a plurality of fine error signals are respectively output. The actuated magnetic field is controlled respectively at the plurality of distinct frequencies at least partially based on at least one of the plurality of coarse error signals, and finely controlled respectively at the plurality of distinct frequencies at least partially based on at least one of the plurality of fine error signals.

An actuated magnetic field is generated at a plurality of distinct frequencies that at least partially cancels an outside magnetic field at the plurality of distinct frequencies, thereby yielding a total residual magnetic field. The total residual magnetic field is coarsely detected and a plurality of coarse error signals are respectively output. The total residual magnetic field is finely detected and a plurality of fine error signals are respectively output. The actuated magnetic field is controlled respectively at the plurality of distinct frequencies at least partially based on at least one of the plurality of coarse error signals, and finely controlled respectively at the plurality of distinct frequencies at least partially based on at least one of the plurality of fine error signals.

At least one magnetic field actuator is configured for generating an actuated magnetic field that at least partially cancels an outside magnetic field, thereby yielding a total residual magnetic field. A plurality of magnetometers are configured for taking measurements of the total residual magnetic field. The magnetometers include a plurality of coarse magnetometers and a plurality of fine magnetometers. A processor is configured for acquiring the total residual magnetic field measurements from the coarse magnetometers, estimating the total residual magnetic field at the fine magnetometers based on total residual magnetic field measurements acquired from the plurality of coarse magnetometers, and controlling the actuated magnetic field at least partially based on the total residual magnetic field estimates at the fine magnetometers in a manner that suppresses the total residual magnetic field at the fine magnetometers to a baseline level, such that at least one of the fine magnetometers is in-range.

A bioelectric current estimation method includes acquiring position information of a nerve in a measurement target region of a subject for which magnetic data is measured with a magnetic sensor, the position information of the nerve being acquired based on a nerve image included in a morphological image of the measurement target region; acquiring a positional relationship between a position of the nerve and a position of the magnetic sensor, based on the acquired position information of the nerve and position information of the magnetic sensor when the magnetic sensor is positioned to face the measurement target region; and estimating a neural activity current, which is generated in association with neural activity of the subject, based on the acquired positional relationship and the magnetic data of the measurement target region measured by the magnetic sensor.

A biometric information display device includes a display controller configured to display a morphological image indicative of a morphology of a subject, on a display, an input controller configured to receive a designation of a specified position on the morphological image, a pathway generating section configured to generate a pathway based on the specified position on the morphological image, and a current extracting section configured to extract current components at a plurality of positions along the pathway, based on current information reconstructed based on magnetic field measurement data generated by the subject. The display controller displays the current components extracted along the pathway on the display.

A magnetic field measuring apparatus that includes a first board having a plurality of first connecting parts, at least one second board connected to the plurality of first connection parts, and a power supply unit supplying power to the first board and the at least one second board so as to measure a magnetic field includes at least one first voltage regulator disposed on the first board to generate a first voltage using power from the power supply unit; and at least one second voltage regulator disposed on any one of the at least one second board to generate a second voltage using the first voltage.

A head-mounted spectrum sensing device is provided which includes an acoustic system, a magnetic system, an ultrasound system, and a control and processing system. The head-mounted spectrum sensing device can judge a risk of dementia according to a thermal image with blood velocity information, a thermal image with magnetic flux information, and a thermal image with ultrasound information.

The present disclosure relates to sensing devices, systems, and their methods of use for aiding transcutaneous magnetic stimulation (tMS) therapy, such as for the treatment, alleviation, and the management of pain. The sensing device being configured for determining and measuring the efficacy thereof. Particularly, the present disclosure is directed to providing sensing devices, systems including the same, and their methods of use in identifying and targeting one or more sources of pain, such as chronic neuropathic pain, as well as for facilitating in the treatment thereof.

A biological data processing apparatus includes an addition averaging processor configured to perform an addition averaging process on measurement data of a magnetic field generated by a living body; an estimator configured to perform an estimation process of estimating an intensity of an action current within the living body based on addition average data acquired by the addition averaging processor; a start instruction acceptor configured to accept a start instruction to start the estimation process by the estimator while measurement of the magnetic field is being performed; and a display configured to display an estimation result obtained by the estimator in response to the start instruction.